To be precise, there was no time to attend.
In early November, Tosaki Kawashima, a renowned geneticist, psychiatrist, and pediatrician in Country R, who is also a mathematician, published a paper in the prestigious medical journal The Lancet commonly referred to domestically as Liuyedao titled “Study on the Harm of Schankwo’s Miracle Drug on Pregnant Women and Fetuses During Clinical Trials.”
In it, he conducted a “meticulous dissection” of the ingredients of the Schankwo miracle drug developed by Jiang Fuyue, laid out the relevant clinical trial data, and ultimately concluded that the so-called “Schankwo miracle drug” was a strongly teratogenic drug, warning countries to exercise caution.
Speaking of Tosaki Kawashima, he has a few indirect connections with Jiang Fuyue.
First, both are recipients of the Lasker Medical Award, Tosaki Kawashima in 2010, and Jiang Fuyue in 2052.
Both achieved fame at a young age, and both earned the award for accomplishments in antiviral drugs and vaccines, showing some resemblance.
Foreign media once even referred to Jiang Fuyue as the “young version of Tosaki Kawashima,” but Jiang Fuyue directly said no and told them never to call her that again.
Her stance was firm, her gaze slightly contemptuous.
A camera caught a journalist from Country R present at the scene turning green. Several times he opened his mouth, probably intending to retort but every time he met Jiang Fuyue’s sharp gaze, he instantly backed down, ending up saying not a single word, his expression twisted.
The next day, this footage was sent back home and uploaded online, where sharp-eyed Chinese netizens spotted it and made it into animated emoji-like reaction images with captions like:
- [Twisted in anger]
- [Clown angry]
- [Fear dominated by Yue]
…
From then on, the term “young version of Tosaki Kawashima” never appeared in foreign media reports again.
Of course, Jiang Fuyue’s ruthless approach also drew criticism.
People said she had just won the award and already offended a senior like Tosaki Kawashima, arrogant and uncultured.
Jiang Fuyue neither denied nor argued.
No matter how the outside world judged, she simply did not accept it. If she disliked something, she disliked it, and she displayed her rejection and disdain clearly, confidently.
Considering the lingering historical grudges between China and Country R that had never been reconciled, people could suddenly understand her actions.
Domestic netizens cheered: Vindicated!
Foreign netizens praised: So bold!
But for the sake of present-day harmony between the two countries (at least on the surface), the matter was quietly dropped and not sensationalized.
The implied meaning: cough… everyone can secretly enjoy it, but publicly, keep appearances, don’t be too obvious.
The above outlines the academic-related connection (and grudge) between Jiang Fuyue and Tosaki Kawashima.
Next, Tosaki Kawashima, as the head of the Tosaki family, is also the father of Tosaki Chiba and Tosaki Naohara.
Coincidentally, Jiang Fuyue has encountered both sons.
First, she defeated the R team led by Tosaki Chiba in an international competition. Later, during an exchange program, in front of all teachers and students at Lin Nan No.1 High School, she played a masterful hand at “qin, chess, calligraphy, and painting,” directly humiliating “chess genius” Tosaki Naohara.
So now, the father himself steps in, coming in ferociously. Is he seeking revenge?
…
Finally, as a mathematician, Tosaki Kawashima, who had achieved considerable success in Country R, had, ten years ago, proposed a new conjecture concerning the J Equation and the supercritical Hermite–Yang–Mills Equation.
However, due to logical flaws in his proof steps, the world-renowned math journal Advances in Mathematics rejected his manuscript.
Tosaki Kawashima loudly protested and appealed multiple times, but to no avail.
Advances in Mathematics was resolute in refusing to publish his “fallacy.”
Yet Tosaki Kawashima insisted that his steps were correct, even publicly insulting the journal, denouncing the editorial team as lacking vision and ability.
At the time, the mathematics community erupted over this. Mathematicians worldwide delved into his conjecture, verifying and rechecking it, and divided into two camps:
One camp argued that since there was insufficient evidence proving Tosaki Kawashima wrong, he should be considered correct.
The other camp argued that while there was insufficient evidence proving him wrong, there was also no precise evidence proving he was right, so it should be treated as an error.
Seeing that so many scholars could not decisively say he was wrong, Tosaki Kawashima became even more confident. To restore his lost face from the rejection, he even attempted to sue Advances in Mathematics.
Fortunately, he stopped in time, not taking it too far.
However, the journal still blacklisted him, issuing an internal notice never to accept submissions from Tosaki Kawashima again.
He didn’t care, after all, no one had proven him wrong, and that was enough for him!
Until…
Jiang Fuyue’s paper, “Variations on the J Equation and Supercritical Hermite–Yang–Mills Equation”, appeared out of nowhere and was accepted by Advances in Mathematics, published in a prominent position.
It contained ample theoretical evidence proving Tosaki Kawashima’s original conjecture was completely wrong.
The slap in the face was resounding.
Tosaki Kawashima was ridiculed across the entire mathematics community: not even as capable as a young girl.
After that, he quietly stopped speaking publicly.
The outside world speculated: embarrassed, he simply withdrew like a turtle!
…
Laboratory.
Xu Kaiqing: “That old guy Tosaki Kawashima is not easy to deal with.”
Old Peter: “Now he says the miracle drug has issues and even laid out all the data, he clearly came prepared.”
Xu Kaiqing: “Prepared doesn’t mean ready, thank you.”
“…Anyway, it’s all the same.”
“The key point is that The Lancet has already publicly published this paper. You don’t need me to explain what that means, right?”
This proves that The Lancet officially recognized the paper’s findings.
The Lancet, published by Elsevier, is internationally recognized as one of the four major comprehensive medical journals.
According to the latest information on The Lancet’s official website, last year’s journal citation reports and Clarivate Analytics’ analysis show an impact factor as high as 60.392.
This demonstrates its influence and authority.
The paper’s discussion of the “drug’s harm to pregnant women and fetuses” mainly follows standards issued by the FDA (U.S. Food and Drug Administration), which classifies drugs into five categories: A, B, C, D, and X.
A: Clinically observed to cause no fetal harm, safe.
B: No fetal harm observed in animal trials, but lacking human clinical data; or harm seen in animals but not confirmed in humans.
C …
Usually, A and B drugs are safe for the fetus and have no side effects, such as multivitamins or antibiotics like penicillins and cephalosporins.
C and D drugs may pose teratogenic or miscarriage risks but benefit the mother; they cannot be used recklessly, e.g., certain antibiotics and hormones.
As for X… based on both animal experiments and clinical data, these are highly harmful to fetuses and are forbidden during pregnancy, e.g., anticancer drugs.
In Tosaki Kawashima’s paper, he arbitrarily classified the Schankwo miracle drug as X-class without FDA approval!
Want to show your support? Go donate at Paypal or Ko-fi to show your appreciation! :)
